Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
Sponsor: Transcend Therapeutics
Summary
This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD. Eligible participants will enter a 4-week Treatment Period where they will be randomized 1:1:1 to receive one of two doses of TSND-201 or placebo, once per week. Following the Treatment Period, participants will enter an 8-week Follow-up Period.
Official title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2026-09-25
Completion Date
2028-02
Last Updated
2026-11-03
Healthy Volunteers
No
Conditions
Interventions
TSND-201
TSND-201 capsules, given orally, once a week for four consecutive weeks
Placebo
Placebo capsules, given orally, once a week for four consecutive weeks
Locations (9)
Mountain View Clinical Research
Denver, Colorado, United States
Bradenton Research Center
Bradenton, Florida, United States
CNS Healthcare
Orlando, Florida, United States
CenExel Tampa
Tampa, Florida, United States
K2 Medical Research Tampa
Tampa, Florida, United States
CenExel Atlanta
Atlanta, Georgia, United States
CenExel Marlton
Marlton, New Jersey, United States
Bio Behavioral Health
Toms River, New Jersey, United States
Cedar Clinical Research
Draper, Utah, United States